nodes	percent_of_prediction	percent_of_DWPC	metapath
Orciprenaline—Isoprenaline—MAPK1—ovarian cancer	0.0346	1	CrCbGaD
Orciprenaline—Fatigue—Altretamine—ovarian cancer	0.0179	0.0185	CcSEcCtD
Orciprenaline—Asthenia—Altretamine—ovarian cancer	0.0149	0.0154	CcSEcCtD
Orciprenaline—Anaphylactoid reaction—Topotecan—ovarian cancer	0.0138	0.0143	CcSEcCtD
Orciprenaline—Dizziness—Altretamine—ovarian cancer	0.0137	0.0142	CcSEcCtD
Orciprenaline—Vomiting—Altretamine—ovarian cancer	0.0132	0.0137	CcSEcCtD
Orciprenaline—Nausea—Altretamine—ovarian cancer	0.0123	0.0128	CcSEcCtD
Orciprenaline—Pain—Carboplatin—ovarian cancer	0.0123	0.0127	CcSEcCtD
Orciprenaline—Cramp muscle—Topotecan—ovarian cancer	0.012	0.0125	CcSEcCtD
Orciprenaline—Body temperature increased—Carboplatin—ovarian cancer	0.0113	0.0117	CcSEcCtD
Orciprenaline—Bronchospasm—Melphalan—ovarian cancer	0.0111	0.0115	CcSEcCtD
Orciprenaline—Sweating—Topotecan—ovarian cancer	0.00988	0.0102	CcSEcCtD
Orciprenaline—Bronchospasm—Vinorelbine—ovarian cancer	0.00972	0.0101	CcSEcCtD
Orciprenaline—Tremor—Chlorambucil—ovarian cancer	0.00847	0.00878	CcSEcCtD
Orciprenaline—Chills—Topotecan—ovarian cancer	0.0083	0.0086	CcSEcCtD
Orciprenaline—Arrhythmia—Melphalan—ovarian cancer	0.00809	0.00838	CcSEcCtD
Orciprenaline—Muscle spasms—Topotecan—ovarian cancer	0.00774	0.00802	CcSEcCtD
Orciprenaline—Arrhythmia—Vinorelbine—ovarian cancer	0.00707	0.00732	CcSEcCtD
Orciprenaline—Cough—Topotecan—ovarian cancer	0.00703	0.00728	CcSEcCtD
Orciprenaline—Hypokalaemia—Paclitaxel—ovarian cancer	0.007	0.00725	CcSEcCtD
Orciprenaline—Cramp muscle—Paclitaxel—ovarian cancer	0.00693	0.00717	CcSEcCtD
Orciprenaline—Cough—Melphalan—ovarian cancer	0.00688	0.00712	CcSEcCtD
Orciprenaline—Myalgia—Topotecan—ovarian cancer	0.00685	0.0071	CcSEcCtD
Orciprenaline—Chest pain—Topotecan—ovarian cancer	0.00685	0.0071	CcSEcCtD
Orciprenaline—Chest pain—Melphalan—ovarian cancer	0.00671	0.00695	CcSEcCtD
Orciprenaline—Myalgia—Melphalan—ovarian cancer	0.00671	0.00695	CcSEcCtD
Orciprenaline—Influenza—Paclitaxel—ovarian cancer	0.00665	0.00689	CcSEcCtD
Orciprenaline—Anaphylactic shock—Topotecan—ovarian cancer	0.00657	0.00681	CcSEcCtD
Orciprenaline—Sweating increased—Paclitaxel—ovarian cancer	0.00648	0.00671	CcSEcCtD
Orciprenaline—Anaphylactic shock—Melphalan—ovarian cancer	0.00643	0.00666	CcSEcCtD
Orciprenaline—Oedema—Melphalan—ovarian cancer	0.00643	0.00666	CcSEcCtD
Orciprenaline—Fatigue—Chlorambucil—ovarian cancer	0.00636	0.00659	CcSEcCtD
Orciprenaline—Hyperhidrosis—Topotecan—ovarian cancer	0.00635	0.00658	CcSEcCtD
Orciprenaline—Pain—Chlorambucil—ovarian cancer	0.00631	0.00654	CcSEcCtD
Orciprenaline—Tachycardia—Melphalan—ovarian cancer	0.00628	0.0065	CcSEcCtD
Orciprenaline—Palpitations—Vinorelbine—ovarian cancer	0.00609	0.0063	CcSEcCtD
Orciprenaline—Cough—Vinorelbine—ovarian cancer	0.00601	0.00622	CcSEcCtD
Orciprenaline—Musculoskeletal discomfort—Topotecan—ovarian cancer	0.00599	0.0062	CcSEcCtD
Orciprenaline—Hypertension—Vinorelbine—ovarian cancer	0.00595	0.00616	CcSEcCtD
Orciprenaline—Cramp muscle—Docetaxel—ovarian cancer	0.00587	0.00608	CcSEcCtD
Orciprenaline—Urticaria—Chlorambucil—ovarian cancer	0.00586	0.00607	CcSEcCtD
Orciprenaline—Myalgia—Vinorelbine—ovarian cancer	0.00586	0.00607	CcSEcCtD
Orciprenaline—Chest pain—Vinorelbine—ovarian cancer	0.00586	0.00607	CcSEcCtD
Orciprenaline—Musculoskeletal discomfort—Melphalan—ovarian cancer	0.00586	0.00607	CcSEcCtD
Orciprenaline—Body temperature increased—Chlorambucil—ovarian cancer	0.00583	0.00604	CcSEcCtD
Orciprenaline—Fatigue—Topotecan—ovarian cancer	0.00566	0.00587	CcSEcCtD
Orciprenaline—Anaphylactic shock—Vinorelbine—ovarian cancer	0.00562	0.00582	CcSEcCtD
Orciprenaline—Pain—Topotecan—ovarian cancer	0.00562	0.00582	CcSEcCtD
Orciprenaline—Fatigue—Melphalan—ovarian cancer	0.00555	0.00575	CcSEcCtD
Orciprenaline—Bronchospasm—Docetaxel—ovarian cancer	0.00554	0.00574	CcSEcCtD
Orciprenaline—Pain—Melphalan—ovarian cancer	0.0055	0.0057	CcSEcCtD
Orciprenaline—Tachycardia—Vinorelbine—ovarian cancer	0.00549	0.00568	CcSEcCtD
Orciprenaline—Hypersensitivity—Chlorambucil—ovarian cancer	0.00544	0.00563	CcSEcCtD
Orciprenaline—Asthenia—Chlorambucil—ovarian cancer	0.0053	0.00548	CcSEcCtD
Orciprenaline—Pruritus—Chlorambucil—ovarian cancer	0.00522	0.00541	CcSEcCtD
Orciprenaline—Urticaria—Topotecan—ovarian cancer	0.00522	0.00541	CcSEcCtD
Orciprenaline—Body temperature increased—Topotecan—ovarian cancer	0.00519	0.00538	CcSEcCtD
Orciprenaline—Musculoskeletal discomfort—Vinorelbine—ovarian cancer	0.00512	0.0053	CcSEcCtD
Orciprenaline—Urticaria—Melphalan—ovarian cancer	0.00511	0.00529	CcSEcCtD
Orciprenaline—Diarrhoea—Chlorambucil—ovarian cancer	0.00505	0.00523	CcSEcCtD
Orciprenaline—Fatigue—Vinorelbine—ovarian cancer	0.00485	0.00502	CcSEcCtD
Orciprenaline—Hypersensitivity—Topotecan—ovarian cancer	0.00484	0.00501	CcSEcCtD
Orciprenaline—Pain—Vinorelbine—ovarian cancer	0.00481	0.00498	CcSEcCtD
Orciprenaline—Chills—Paclitaxel—ovarian cancer	0.00477	0.00495	CcSEcCtD
Orciprenaline—Arrhythmia—Paclitaxel—ovarian cancer	0.00475	0.00492	CcSEcCtD
Orciprenaline—Hypersensitivity—Melphalan—ovarian cancer	0.00474	0.00491	CcSEcCtD
Orciprenaline—Asthenia—Topotecan—ovarian cancer	0.00471	0.00488	CcSEcCtD
Orciprenaline—Vomiting—Chlorambucil—ovarian cancer	0.00469	0.00486	CcSEcCtD
Orciprenaline—Pruritus—Topotecan—ovarian cancer	0.00465	0.00481	CcSEcCtD
Orciprenaline—Asthenia—Melphalan—ovarian cancer	0.00462	0.00478	CcSEcCtD
Orciprenaline—Pruritus—Melphalan—ovarian cancer	0.00455	0.00471	CcSEcCtD
Orciprenaline—Tension—Paclitaxel—ovarian cancer	0.00455	0.00471	CcSEcCtD
Orciprenaline—Anaphylactoid reaction—Epirubicin—ovarian cancer	0.00454	0.00471	CcSEcCtD
Orciprenaline—Dysgeusia—Paclitaxel—ovarian cancer	0.00454	0.0047	CcSEcCtD
Orciprenaline—Nervousness—Paclitaxel—ovarian cancer	0.0045	0.00466	CcSEcCtD
Orciprenaline—Diarrhoea—Topotecan—ovarian cancer	0.0045	0.00466	CcSEcCtD
Orciprenaline—Urticaria—Vinorelbine—ovarian cancer	0.00447	0.00462	CcSEcCtD
Orciprenaline—Muscle spasms—Paclitaxel—ovarian cancer	0.00445	0.00461	CcSEcCtD
Orciprenaline—Body temperature increased—Vinorelbine—ovarian cancer	0.00444	0.0046	CcSEcCtD
Orciprenaline—Diarrhoea—Melphalan—ovarian cancer	0.0044	0.00456	CcSEcCtD
Orciprenaline—Nausea—Chlorambucil—ovarian cancer	0.00438	0.00454	CcSEcCtD
Orciprenaline—Vision blurred—Paclitaxel—ovarian cancer	0.00437	0.00452	CcSEcCtD
Orciprenaline—Dizziness—Topotecan—ovarian cancer	0.00434	0.0045	CcSEcCtD
Orciprenaline—Tremor—Paclitaxel—ovarian cancer	0.00434	0.0045	CcSEcCtD
Orciprenaline—Anaphylactoid reaction—Doxorubicin—ovarian cancer	0.0042	0.00435	CcSEcCtD
Orciprenaline—Vomiting—Topotecan—ovarian cancer	0.00418	0.00433	CcSEcCtD
Orciprenaline—Syncope—Paclitaxel—ovarian cancer	0.00415	0.0043	CcSEcCtD
Orciprenaline—Hypersensitivity—Vinorelbine—ovarian cancer	0.00414	0.00429	CcSEcCtD
Orciprenaline—Headache—Topotecan—ovarian cancer	0.00412	0.00426	CcSEcCtD
Orciprenaline—Palpitations—Paclitaxel—ovarian cancer	0.00409	0.00424	CcSEcCtD
Orciprenaline—Vomiting—Melphalan—ovarian cancer	0.00409	0.00424	CcSEcCtD
Orciprenaline—Loss of consciousness—Paclitaxel—ovarian cancer	0.00407	0.00422	CcSEcCtD
Orciprenaline—Chills—Docetaxel—ovarian cancer	0.00405	0.00419	CcSEcCtD
Orciprenaline—Cough—Paclitaxel—ovarian cancer	0.00404	0.00419	CcSEcCtD
Orciprenaline—Asthenia—Vinorelbine—ovarian cancer	0.00403	0.00418	CcSEcCtD
Orciprenaline—Arrhythmia—Docetaxel—ovarian cancer	0.00403	0.00417	CcSEcCtD
Orciprenaline—Hypokalaemia—Epirubicin—ovarian cancer	0.004	0.00415	CcSEcCtD
Orciprenaline—Hypertension—Paclitaxel—ovarian cancer	0.004	0.00414	CcSEcCtD
Orciprenaline—Pruritus—Vinorelbine—ovarian cancer	0.00398	0.00412	CcSEcCtD
Orciprenaline—Myalgia—Paclitaxel—ovarian cancer	0.00394	0.00408	CcSEcCtD
Orciprenaline—Chest pain—Paclitaxel—ovarian cancer	0.00394	0.00408	CcSEcCtD
Orciprenaline—Nausea—Topotecan—ovarian cancer	0.0039	0.00404	CcSEcCtD
Orciprenaline—Dry mouth—Paclitaxel—ovarian cancer	0.00386	0.00399	CcSEcCtD
Orciprenaline—Diarrhoea—Vinorelbine—ovarian cancer	0.00385	0.00398	CcSEcCtD
Orciprenaline—Dysgeusia—Docetaxel—ovarian cancer	0.00384	0.00398	CcSEcCtD
Orciprenaline—Nausea—Melphalan—ovarian cancer	0.00382	0.00396	CcSEcCtD
Orciprenaline—Influenza—Epirubicin—ovarian cancer	0.0038	0.00394	CcSEcCtD
Orciprenaline—Asthma—Epirubicin—ovarian cancer	0.0038	0.00394	CcSEcCtD
Orciprenaline—Anaphylactic shock—Paclitaxel—ovarian cancer	0.00378	0.00392	CcSEcCtD
Orciprenaline—Oedema—Paclitaxel—ovarian cancer	0.00378	0.00392	CcSEcCtD
Orciprenaline—Muscle spasms—Docetaxel—ovarian cancer	0.00377	0.00391	CcSEcCtD
Orciprenaline—Shock—Paclitaxel—ovarian cancer	0.00372	0.00385	CcSEcCtD
Orciprenaline—Dizziness—Vinorelbine—ovarian cancer	0.00372	0.00385	CcSEcCtD
Orciprenaline—Hypokalaemia—Doxorubicin—ovarian cancer	0.0037	0.00384	CcSEcCtD
Orciprenaline—Tachycardia—Paclitaxel—ovarian cancer	0.00369	0.00382	CcSEcCtD
Orciprenaline—Hyperhidrosis—Paclitaxel—ovarian cancer	0.00365	0.00379	CcSEcCtD
Orciprenaline—Vomiting—Vinorelbine—ovarian cancer	0.00357	0.0037	CcSEcCtD
Orciprenaline—Headache—Vinorelbine—ovarian cancer	0.00352	0.00365	CcSEcCtD
Orciprenaline—Syncope—Docetaxel—ovarian cancer	0.00352	0.00365	CcSEcCtD
Orciprenaline—Asthma—Doxorubicin—ovarian cancer	0.00352	0.00364	CcSEcCtD
Orciprenaline—Influenza—Doxorubicin—ovarian cancer	0.00352	0.00364	CcSEcCtD
Orciprenaline—Palpitations—Docetaxel—ovarian cancer	0.00347	0.00359	CcSEcCtD
Orciprenaline—Loss of consciousness—Docetaxel—ovarian cancer	0.00345	0.00357	CcSEcCtD
Orciprenaline—Musculoskeletal discomfort—Paclitaxel—ovarian cancer	0.00344	0.00357	CcSEcCtD
Orciprenaline—Cough—Docetaxel—ovarian cancer	0.00343	0.00355	CcSEcCtD
Orciprenaline—Insomnia—Paclitaxel—ovarian cancer	0.00342	0.00354	CcSEcCtD
Orciprenaline—Hypertension—Docetaxel—ovarian cancer	0.00339	0.00351	CcSEcCtD
Orciprenaline—Drowsiness—Epirubicin—ovarian cancer	0.00339	0.00351	CcSEcCtD
Orciprenaline—Somnolence—Paclitaxel—ovarian cancer	0.00336	0.00348	CcSEcCtD
Orciprenaline—Chest pain—Docetaxel—ovarian cancer	0.00334	0.00346	CcSEcCtD
Orciprenaline—Myalgia—Docetaxel—ovarian cancer	0.00334	0.00346	CcSEcCtD
Orciprenaline—Nausea—Vinorelbine—ovarian cancer	0.00334	0.00346	CcSEcCtD
Orciprenaline—Dry mouth—Docetaxel—ovarian cancer	0.00327	0.00339	CcSEcCtD
Orciprenaline—Fatigue—Paclitaxel—ovarian cancer	0.00326	0.00338	CcSEcCtD
Orciprenaline—Sweating—Epirubicin—ovarian cancer	0.00325	0.00337	CcSEcCtD
Orciprenaline—Pain—Paclitaxel—ovarian cancer	0.00323	0.00335	CcSEcCtD
Orciprenaline—Anaphylactic shock—Docetaxel—ovarian cancer	0.0032	0.00332	CcSEcCtD
Orciprenaline—Oedema—Docetaxel—ovarian cancer	0.0032	0.00332	CcSEcCtD
Orciprenaline—Shock—Docetaxel—ovarian cancer	0.00315	0.00327	CcSEcCtD
Orciprenaline—Drowsiness—Doxorubicin—ovarian cancer	0.00314	0.00325	CcSEcCtD
Orciprenaline—Tachycardia—Docetaxel—ovarian cancer	0.00313	0.00324	CcSEcCtD
Orciprenaline—Sweating—Doxorubicin—ovarian cancer	0.00301	0.00311	CcSEcCtD
Orciprenaline—Urticaria—Paclitaxel—ovarian cancer	0.003	0.00311	CcSEcCtD
Orciprenaline—Body temperature increased—Paclitaxel—ovarian cancer	0.00299	0.0031	CcSEcCtD
Orciprenaline—Musculoskeletal discomfort—Docetaxel—ovarian cancer	0.00292	0.00302	CcSEcCtD
Orciprenaline—Insomnia—Docetaxel—ovarian cancer	0.0029	0.003	CcSEcCtD
Orciprenaline—Somnolence—Docetaxel—ovarian cancer	0.00285	0.00295	CcSEcCtD
Orciprenaline—Hypersensitivity—Paclitaxel—ovarian cancer	0.00279	0.00289	CcSEcCtD
Orciprenaline—Fatigue—Docetaxel—ovarian cancer	0.00276	0.00286	CcSEcCtD
Orciprenaline—Pain—Docetaxel—ovarian cancer	0.00274	0.00284	CcSEcCtD
Orciprenaline—Chills—Epirubicin—ovarian cancer	0.00273	0.00283	CcSEcCtD
Orciprenaline—Arrhythmia—Epirubicin—ovarian cancer	0.00272	0.00281	CcSEcCtD
Orciprenaline—Asthenia—Paclitaxel—ovarian cancer	0.00271	0.00281	CcSEcCtD
Orciprenaline—Pruritus—Paclitaxel—ovarian cancer	0.00267	0.00277	CcSEcCtD
Orciprenaline—Tension—Epirubicin—ovarian cancer	0.0026	0.00269	CcSEcCtD
Orciprenaline—Dysgeusia—Epirubicin—ovarian cancer	0.00259	0.00269	CcSEcCtD
Orciprenaline—Diarrhoea—Paclitaxel—ovarian cancer	0.00259	0.00268	CcSEcCtD
Orciprenaline—Nervousness—Epirubicin—ovarian cancer	0.00257	0.00266	CcSEcCtD
Orciprenaline—Muscle spasms—Epirubicin—ovarian cancer	0.00255	0.00264	CcSEcCtD
Orciprenaline—Body temperature increased—Docetaxel—ovarian cancer	0.00253	0.00262	CcSEcCtD
Orciprenaline—Chills—Doxorubicin—ovarian cancer	0.00253	0.00262	CcSEcCtD
Orciprenaline—Arrhythmia—Doxorubicin—ovarian cancer	0.00251	0.0026	CcSEcCtD
Orciprenaline—Dizziness—Paclitaxel—ovarian cancer	0.0025	0.00259	CcSEcCtD
Orciprenaline—Vision blurred—Epirubicin—ovarian cancer	0.0025	0.00259	CcSEcCtD
Orciprenaline—Tension—Doxorubicin—ovarian cancer	0.0024	0.00249	CcSEcCtD
Orciprenaline—Vomiting—Paclitaxel—ovarian cancer	0.0024	0.00249	CcSEcCtD
Orciprenaline—Dysgeusia—Doxorubicin—ovarian cancer	0.0024	0.00249	CcSEcCtD
Orciprenaline—Nervousness—Doxorubicin—ovarian cancer	0.00238	0.00247	CcSEcCtD
Orciprenaline—Syncope—Epirubicin—ovarian cancer	0.00237	0.00246	CcSEcCtD
Orciprenaline—Headache—Paclitaxel—ovarian cancer	0.00237	0.00245	CcSEcCtD
Orciprenaline—Hypersensitivity—Docetaxel—ovarian cancer	0.00236	0.00245	CcSEcCtD
Orciprenaline—Muscle spasms—Doxorubicin—ovarian cancer	0.00236	0.00244	CcSEcCtD
Orciprenaline—Palpitations—Epirubicin—ovarian cancer	0.00234	0.00242	CcSEcCtD
Orciprenaline—Loss of consciousness—Epirubicin—ovarian cancer	0.00233	0.00241	CcSEcCtD
Orciprenaline—Cough—Epirubicin—ovarian cancer	0.00231	0.00239	CcSEcCtD
Orciprenaline—Vision blurred—Doxorubicin—ovarian cancer	0.00231	0.00239	CcSEcCtD
Orciprenaline—Asthenia—Docetaxel—ovarian cancer	0.0023	0.00238	CcSEcCtD
Orciprenaline—Hypertension—Epirubicin—ovarian cancer	0.00229	0.00237	CcSEcCtD
Orciprenaline—Pruritus—Docetaxel—ovarian cancer	0.00227	0.00235	CcSEcCtD
Orciprenaline—Chest pain—Epirubicin—ovarian cancer	0.00225	0.00234	CcSEcCtD
Orciprenaline—Myalgia—Epirubicin—ovarian cancer	0.00225	0.00234	CcSEcCtD
Orciprenaline—Nausea—Paclitaxel—ovarian cancer	0.00225	0.00233	CcSEcCtD
Orciprenaline—Dry mouth—Epirubicin—ovarian cancer	0.0022	0.00228	CcSEcCtD
Orciprenaline—Syncope—Doxorubicin—ovarian cancer	0.0022	0.00228	CcSEcCtD
Orciprenaline—Diarrhoea—Docetaxel—ovarian cancer	0.00219	0.00227	CcSEcCtD
Orciprenaline—Palpitations—Doxorubicin—ovarian cancer	0.00217	0.00224	CcSEcCtD
Orciprenaline—Anaphylactic shock—Epirubicin—ovarian cancer	0.00216	0.00224	CcSEcCtD
Orciprenaline—Oedema—Epirubicin—ovarian cancer	0.00216	0.00224	CcSEcCtD
Orciprenaline—Loss of consciousness—Doxorubicin—ovarian cancer	0.00215	0.00223	CcSEcCtD
Orciprenaline—Cough—Doxorubicin—ovarian cancer	0.00214	0.00221	CcSEcCtD
Orciprenaline—Shock—Epirubicin—ovarian cancer	0.00213	0.0022	CcSEcCtD
Orciprenaline—Dizziness—Docetaxel—ovarian cancer	0.00212	0.00219	CcSEcCtD
Orciprenaline—Hypertension—Doxorubicin—ovarian cancer	0.00212	0.00219	CcSEcCtD
Orciprenaline—Tachycardia—Epirubicin—ovarian cancer	0.00211	0.00218	CcSEcCtD
Orciprenaline—Hyperhidrosis—Epirubicin—ovarian cancer	0.00209	0.00216	CcSEcCtD
Orciprenaline—Myalgia—Doxorubicin—ovarian cancer	0.00209	0.00216	CcSEcCtD
Orciprenaline—Chest pain—Doxorubicin—ovarian cancer	0.00209	0.00216	CcSEcCtD
Orciprenaline—Dry mouth—Doxorubicin—ovarian cancer	0.00204	0.00211	CcSEcCtD
Orciprenaline—Vomiting—Docetaxel—ovarian cancer	0.00204	0.00211	CcSEcCtD
Orciprenaline—Headache—Docetaxel—ovarian cancer	0.00201	0.00208	CcSEcCtD
Orciprenaline—Anaphylactic shock—Doxorubicin—ovarian cancer	0.002	0.00207	CcSEcCtD
Orciprenaline—Oedema—Doxorubicin—ovarian cancer	0.002	0.00207	CcSEcCtD
Orciprenaline—Musculoskeletal discomfort—Epirubicin—ovarian cancer	0.00197	0.00204	CcSEcCtD
Orciprenaline—Shock—Doxorubicin—ovarian cancer	0.00197	0.00204	CcSEcCtD
Orciprenaline—Insomnia—Epirubicin—ovarian cancer	0.00195	0.00202	CcSEcCtD
Orciprenaline—Tachycardia—Doxorubicin—ovarian cancer	0.00195	0.00202	CcSEcCtD
Orciprenaline—Hyperhidrosis—Doxorubicin—ovarian cancer	0.00193	0.002	CcSEcCtD
Orciprenaline—Somnolence—Epirubicin—ovarian cancer	0.00192	0.00199	CcSEcCtD
Orciprenaline—Nausea—Docetaxel—ovarian cancer	0.0019	0.00197	CcSEcCtD
Orciprenaline—Fatigue—Epirubicin—ovarian cancer	0.00186	0.00193	CcSEcCtD
Orciprenaline—Pain—Epirubicin—ovarian cancer	0.00185	0.00191	CcSEcCtD
Orciprenaline—Musculoskeletal discomfort—Doxorubicin—ovarian cancer	0.00182	0.00189	CcSEcCtD
Orciprenaline—Insomnia—Doxorubicin—ovarian cancer	0.00181	0.00187	CcSEcCtD
Orciprenaline—Somnolence—Doxorubicin—ovarian cancer	0.00178	0.00184	CcSEcCtD
Orciprenaline—Fatigue—Doxorubicin—ovarian cancer	0.00172	0.00179	CcSEcCtD
Orciprenaline—Urticaria—Epirubicin—ovarian cancer	0.00172	0.00178	CcSEcCtD
Orciprenaline—Pain—Doxorubicin—ovarian cancer	0.00171	0.00177	CcSEcCtD
Orciprenaline—Body temperature increased—Epirubicin—ovarian cancer	0.00171	0.00177	CcSEcCtD
Orciprenaline—Hypersensitivity—Epirubicin—ovarian cancer	0.00159	0.00165	CcSEcCtD
Orciprenaline—Urticaria—Doxorubicin—ovarian cancer	0.00159	0.00165	CcSEcCtD
Orciprenaline—Body temperature increased—Doxorubicin—ovarian cancer	0.00158	0.00164	CcSEcCtD
Orciprenaline—Asthenia—Epirubicin—ovarian cancer	0.00155	0.00161	CcSEcCtD
Orciprenaline—Pruritus—Epirubicin—ovarian cancer	0.00153	0.00158	CcSEcCtD
Orciprenaline—Diarrhoea—Epirubicin—ovarian cancer	0.00148	0.00153	CcSEcCtD
Orciprenaline—Hypersensitivity—Doxorubicin—ovarian cancer	0.00147	0.00153	CcSEcCtD
Orciprenaline—Asthenia—Doxorubicin—ovarian cancer	0.00143	0.00149	CcSEcCtD
Orciprenaline—Dizziness—Epirubicin—ovarian cancer	0.00143	0.00148	CcSEcCtD
Orciprenaline—Pruritus—Doxorubicin—ovarian cancer	0.00141	0.00147	CcSEcCtD
Orciprenaline—Vomiting—Epirubicin—ovarian cancer	0.00137	0.00142	CcSEcCtD
Orciprenaline—Diarrhoea—Doxorubicin—ovarian cancer	0.00137	0.00142	CcSEcCtD
Orciprenaline—Headache—Epirubicin—ovarian cancer	0.00135	0.0014	CcSEcCtD
Orciprenaline—Dizziness—Doxorubicin—ovarian cancer	0.00132	0.00137	CcSEcCtD
Orciprenaline—Nausea—Epirubicin—ovarian cancer	0.00128	0.00133	CcSEcCtD
Orciprenaline—Vomiting—Doxorubicin—ovarian cancer	0.00127	0.00132	CcSEcCtD
Orciprenaline—Headache—Doxorubicin—ovarian cancer	0.00125	0.0013	CcSEcCtD
Orciprenaline—Nausea—Doxorubicin—ovarian cancer	0.00119	0.00123	CcSEcCtD
